Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study.
Miaomiao YangHongqiu PanLihuan LuXiaomin HeHongbo ChenBilin TaoWenpei LiuHonggang YiShao-Wen TangPublished in: BMJ open (2019)
This study protocol has been approved by the ethics committees of Nanjing Medical University. All patients will give written informed consent before enrollment. The findings of the study will be published in peer-reviewed journals and will be presented at national and international conferences.
Keyphrases
- randomized controlled trial
- study protocol
- end stage renal disease
- clinical trial
- ejection fraction
- mycobacterium tuberculosis
- newly diagnosed
- prognostic factors
- peritoneal dialysis
- systematic review
- hiv aids
- health insurance
- hiv infected
- patient reported outcomes
- human immunodeficiency virus
- electronic health record